October 10 2024
Advocate Angle: An Interview with Laurel Pracht: Making Strides to Fund the Future in Ovarian Cancer Research
Our NRG Communications team interviewed Laurel to discuss the fundraising efforts and her passions surrounding cancer research and health equities. Read more
October 10 2024
Navigating the Vast World of Clinical Research Following an Adolescent Young Adult (AYA) Cancer Diagnosis
Advocate Angle by Jade Gibson an NRG Oncology Patient Advocate Read more
September 12 2024
Adding Stereotactic Radiation Therapy to Immune Therapy for Patients with Advanced Renal Cell Cancer (NRG-GU012, The “SAMURAI” Study)
NRG-GU012: Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI) Read more
September 12 2024
Comparing Stereotactic Radiosurgery to Fractionated Stereotactic Radiosurgery for Patients with Cancer that has Spread to the Brain (NRG-BN013)
NRG-BN013: Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases Read more
September 12 2024
My Hereditary Cancer Journey: Looking Back, Look Forward
Article by Diane Rose an NRG Oncology Patient Advocate Read more
January 17 2024
A Message from the Chairs of NRG Oncology’s Research Strategy Committee
2023: The Year in Review Read more
January 17 2024
Cervical Cancer Awareness Month
2023 Cervical Highlights Read more
November 14 2023
Pancreatic Cancer Awareness Month
Updates from the NRG Oncology Pancreatic Cancer Working Group Read more
November 14 2023
National Family Caregivers Month
The Caregiver Experience with Clinical Trials: Understanding the Emotions and Clarifying the Details for Patients Read more
October 24 2023
New Vice Chair named for NRG Health Disparities Committee (HDC)
Dr. Evan Graboyes named HDC Vice Chair, effective immediately Read more